Compatible with Beta Bionics’ proprietary and FDA-approved interoperable automated glycemic controller (iAGC), the first and ...
Researchers evaluated an allogeneic umbilical cord cell therapy in T1DM. A single dose provided durable insulin preservation, ...
Please provide your email address to receive an email when new articles are posted on . Weiner: Is insulin pump therapy recommended for people with type 2 diabetes who require basal-bolus therapy?
Explore the potential benefits and risks of using type 2 diabetes drugs like Ozempic and metformin off-label to manage weight ...
Morning Overview on MSN
Vertex Pharmaceuticals plans to submit its stem cell–derived insulin therapy to the FDA in 2026 after 12 patients with type 1 diabetes began producing their own insulin
For the roughly 1.6 million Americans living with type 1 diabetes, the daily calculus of insulin injections, continuous ...
“Once-weekly IcoSema achieved noninferior A1c reduction and superiority in change in bodyweight, weekly total insulin dose, and hypoglycemia rates vs daily BBT [basal-bolus therapy], suggesting that ...
Insulin resistance plays a role in many diseases. The new research provides insights into why insulin resistance appears to be associated with neurodegenerative disorders. Corresponding author Kai ...
With better screening for type 1 diabetes and a new treatment called TZield, the outlook is improving for people with the ...
Key opportunities in the insulin delivery devices market include advancements in technology leading to user-friendly, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results